Related Experiment Video

Updated: Jun 6, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

[Antidepressant therapy in coronary artery disease]

C Lange-Asschenfeldt1, F Lederbogen

  • 1Klinik und Poliklinik für Psychiatrie und Psychotherapie, LVR-Klinikum, Heinrich-Heine-Universität, Bergische Landstraße 2, 40629, Düsseldorf. christian.lange-asschenfeldt@lvr.de

Der Nervenarzt
|November 27, 2010
PubMed

Insights

Depression independently increases coronary artery disease (CAD) risk and cardiac death. Managing depression in heart patients requires careful treatment to avoid side effects and reduce cardiac risk.

Area of Science:

  • Cardiology
  • Psychiatry
  • Vascular Medicine

Context:

  • Depression is a significant independent risk factor for coronary artery disease (CAD).
  • Comorbid depressive disorder in CAD patients elevates risks for cardiac events and mortality.
  • Major depression affects up to 20% of acute myocardial infarction survivors, increasing cardiac death risk fivefold within 6 months.

Purpose:

  • To review the pathophysiological and prognostic significance of comorbid depression in CAD.
  • To evaluate the risks and benefits of available treatment options for depression in CAD patients.
  • To provide guidance on managing affective disorders and cardiac risk in heart patients.

Summary:

  • Depression significantly impacts cardiovascular health, acting as an independent risk factor for CAD and worsening outcomes in patients with existing heart conditions.
  • Patients with comorbid depression and CAD face substantially higher risks of adverse cardiac events and mortality.
  • Treatment of depression in CAD patients necessitates adherence to established guidelines, with careful consideration of potential cardiac side effects of antidepressants and the benefits of psychotherapy.

Impact:

  • Highlights the critical need for integrated care addressing both mental health and cardiac well-being in patients with CAD.
  • Informs clinical practice regarding the careful selection of antidepressant therapies and psychotherapeutic interventions for individuals with comorbid depression and CAD.
  • Emphasizes the prognostic importance of recognizing and treating depression to improve survival rates and reduce cardiac events in coronary artery disease patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...